Retatrutide may become an option in the future if: Its approved by the MHRA and recommended by NICE, which is likely several years away You havent responded well to existing GLP-1 medications, and a triple agonist offers a different approach worth trying The Phase 3 safety data on heart rate, irregular heartbeats, and dysesthesia are reassuring once its complete For most people in the UK, the choice now is between Wegovy and Mounjaro, supported by a structured weight management service
The National Institute for Health and Care Excellence, known as NICE, is still reviewing it to decide whether the NHS should fund it
Your body adjusts
Ketones began to attract a lot of attention by the late 19th century because physicians found them to be abundant in the urine of diabetic patients who went into a coma
Free Reconstitution Calculator Enter your vial size, BAC water volume, and desired dose to get exact insulin units
Metabolic Rate Retatrutide has the potential to increase metabolic rate, which is the rate at which the body burns through energy both at rest and during activity